Pluristyx and Humacyte Announce Partnership
Pluristyx, a renowned cellular therapy developer, has partnered with Humacyte, a biotechnology company specializing in bioengineered human tissue. This...
Pluristyx, a renowned cellular therapy developer, has partnered with Humacyte, a biotechnology company specializing in bioengineered human tissue. This...
SEQSTER and Antidote have revolutionized patient matching and clinical research efficiency. SEQSTER’s patient-centric healthcare platform provides a comprehensive view...
Genexine, a Korean biopharmaceutical company, has merged with EPD Biotherapeutics, specializing in targeted protein degradation (TPD) technology. This merger...
ACTICOR BIOTECH, a clinical-stage pharmaceutical company, reports its voting rights and shares as of May 31, 2024. The company...
N-Power Medicine has secured initial funding in a Series B round, boosting its total funding to $72 million. Led...
The European Medicines Agency (EMA) has recommended granting marketing authorization for epcoritamab, a monoclonal antibody for treating relapsed or...
Pfizer and BioNTech‘s Omicron JN.1-adapted COVID-19 vaccine (COMIRNATY® JN.1) has received a positive recommendation for marketing authorization from the...
Tectonic Therapeutic, Inc. (TECX) has merged with AVROBIO, Inc. and will operate as Tectonic Therapeutic, Inc., trading on Nasdaq...
Greenphire unveils a groundbreaking Patient Experience Dataset, establishing the industry’s first repository of global patient-level insights. This dataset provides...
Ensem Therapeutics has partnered with BeiGene to advance ETX-197, now known as BG-68501, into clinical trials. BG-68501 is a...